Conference Call with Bodal Chemicals Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Bodal Chemicals Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals firm Bodal Chemicals announced Q1FY23 Result : Overall business performance for Q1FY23 has been satisfactory as the company's total revenue for the quarter stood at Rs 4,627 mn, a growth of 8% on a YoY basis. Consumption of end-user industries has been on edge headed by many uncertain global events. Although, the rising raw material price has been positively reflected in our Basic Chemicals and Chlor Alkali business which has partly negated the adverse performance of the Dye Intermediate business. The Dyestuff business has been growing considerably over the last few quarters. Q1FY23 revenue stood at Rs 1,503 mn compared to Rs 1,311 mn in Q1FY22, a growth of 15% on a YoY basis. In Q1FY23, Dye Intermediate revenue stood at Rs 1,220 mn, as compared to Rs 1,522 mn in Q1FY22. Average prices of key products i.e. H Acid and Vinyl Sulphone have been moderated in Q1FY23 to Rs 473 per kg and Rs 290 per kg, respectively, as a result of the lackluster response from textile industries after being hurt by the high price of cotton. Although, Our basic chemical division also reported healthy performance led by higher raw material prices. In last few weeks, we are seeing some green shoots events and we anticipated a healthy performance in the upcoming quarters. The Chlor Alkali business continues to flourish in Q1FY23, with revenue of Rs 855 mn driven by a healthy volume uptick and higher realization from caustic soda. Our subsidiary Sener Boya has reported a notable performance whereas other Subsidiaries have reported weak performance, especially the SPS unit due to low demand for Dye Intermediate products. The upgradation of the Rajpura unit is on track and is expected to be complete by Oct’22. Post completion, our Chlor Alkali business will contribute a significant pie of total revenue. On the other hand, Saykha Greenfield Project is expected to start trial run in Q1FY24. Result PDF
Conference Call with Bodal Chemicals Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.